The effects of glycemic control on seizures and seizure-induced excitotoxic cell death

BMC Neuroscience

Volumn 13, Issue 1, 2012, Pages

  Schauwecker, Paula E ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Epileptic seizures; Excitotoxicity; Glucose; Hippocampus; Hyperglycemia; Hypoglycemia; Kainic acid; Mouse strain

Indexed keywords

GLUCOSE; KAINIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONTROLLED STUDY; DISEASE SEVERITY; EXCITOTOXICITY; GLYCEMIC CONTROL; HIPPOCAMPUS; HYPERGLYCEMIA; HYPOGLYCEMIA; MOUSE; NEUROPATHOLOGY; NONHUMAN; SEIZURE;

ANIMALS; CELL COUNT; CELL DEATH; DISEASE MODELS, ANIMAL; FASTING; GLUCOSE; HIPPOCAMPUS; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN; KAINIC ACID; MALE; MICE; MICE, INBRED STRAINS; NEUROTOXINS; PHOSPHOPYRUVATE HYDRATASE; STATUS EPILEPTICUS; STREPTOZOCIN;

EID: 84864529302     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-13-94     Document Type: Article

References (84)

1. Browne TR, Holmes GL. Epilepsy. New Engl J Med 2001, 344:1145-1151. 10.1056/NEJM200104123441507, 11297707.
2. Chang BS, Lowenstein DH. Epilepsy. N Engl J Med 2003, 349:1257-1266. 10.1056/NEJMra022308, 14507951.
3. Bien CG, Kurthen M, Baron K, Lux S, Helmstaedter C, Schramm J, Elger CE. Long-term seizure outcome and antiepileptic drug treatment in surgically treated temporal lobe epilepsy patients: a controlled study. Epilepsia 2001, 42:1416-1421.
4. Cavazos JE, Jones SM, Cross DJ. Sprouting and synaptic reorganization in the subiculum and CA1 region of the hippocampus in acute and chronic models of partial-onset epilepsy. Neuroscience 2004, 126:677-688. 10.1016/j.neuroscience.2004.04.014, 3179906, 15183517.
5. Babb TL, Brown WJ. Neuronal, dendritic, and vascular profiles of human temporal lobe epilepsy correlated with cellular physiology in vivo. Adv Neurol 1986, 44:949-966.
6. Wolf HK, Campos MG, Zentner J, Hufnagel A, Schramm J, Elger CE, Wiestler OD. Surgical pathology of temporal lobe epilepsy. Experience with 216 cases. J Neuropathol Exp Neurol 52, 52:499-506.
7. Engel J, Babb TL, Crandall PH. Surgical treatment of epilepsy: opportunities for research into basic mechanisms of human brain function. Acta Neurochir Suppl 1987, 46:3-8.
8. DeLorenzo RJ, Pellock JM, Towne AR, Boggs JG. Epidemiology of status epilepticus. J Clin Neurophysiol 1995, 12:316-325.
9. Fountain NB, Lothman EW. Pathophysiology of status epilepticus. J Clin Neurophysiol 1995, 12:326-342.
10. Goulon M, Lévy-Alcover MA, Nouailhat F. Status epilepticus in the adult. Epidemiologic and clinical study in an intensive care unit. Rev Electroencephalogr Neurophysiol Clin 1985, 14:277-285. 10.1016/S0370-4475(85)80048-4, 4023353.
11. Mathern GW, Cifuentes F, Leite JP, Pretorius JK, Babb TL. Hippocampal EEG excitability and chronic spontaneous seizures are associated with aberrant synaptic reorganization in the rat intrahippocampal kainate model. Electroencephalogr Clin Neurophysiol 1993, 87:326-339. 10.1016/0013-4694(93)90186-Y, 7693444.
12. Bouilleret V, Ridoux V, Depaulis A, Marescaux C, Nehlig A, Le Gal La Salle G. Recurrent seizures and hippocampal sclerosis following intrahippocampal kainate injection in adult mice: electroencephalography, histopathology and synaptic reorganization similar to mesial temporal lobe epilepsy. Neuroscience 1999, 89:717-729. 10.1016/S0306-4522(98)00401-1, 10199607.
13. Davenport CJ, Brown WJ, Babb TL. Sprouting of GABAergic and mossy fiber axons in dentate gyrus following intrahippocampal kainate in the rat. Exp Neurol 1990, 109:180-190. 10.1016/0014-4886(90)90072-Z, 1696207.
14. Nitecka L, Tremblay E, Charton G, Bouillot JP, Berger ML, Ben-Ari Y. Maturation of kainic acid seizure-brain damage syndrome in the rat. II. Histopathological sequelae. Neuroscience 1984, 13:1073-1094. 10.1016/0306-4522(84)90289-6, 6527790.
15. Olney JW, Collins RC, Sloviter RS. Excitotoxic mechanisms of epileptic brain damage. Adv Neurol 1986, 44:857-877.
16. Sutula TP. Experimental models of temporal lobe epilepsy: new insights from the study of kindling and synaptic reorganization. Epilepsia 1990, 31:S45-S54.
17. Coyle JT. Neurotoxic action of kainic acid. J Neurochem 1983, 41:1-11.
18. Ben-Ari Y. Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience 1985, 14:375-403. 10.1016/0306-4522(85)90299-4, 2859548.
19. Nadler JV, Evenson DA. Use of excitatory amino acids to make axon-sparing lesions of hypothalamus. Methods Enzymol 1983, 103:393-400.
20. Nadler JV, Perry VW, Cotman CW. Intraventricular kainic acid preferentially destroys hippocampal pyramidal cells. Nature 1978, 271:676-677. 10.1038/271676a0, 625338.
21. Schwob JE, Fuller T, Price JL, Olney JW. Widespread patterns of neuronal damage following systemic administration of kainic acid: a histological study. Neuroscience 1980, 9:991-1014.
22. Ben-Ari Y, Cossart R. Kainate, a double agent that generates seizures: two decades of progress. Trends Neurosci 2000, 23:580-587. 10.1016/S0166-2236(00)01659-3, 11074268.
23. Santos JB, Schauwecker PE. Protection provided by cyclosporin A against excitotoxic neuronal death is genotype dependent. Epilepsia 2003, 44:995-1002. 10.1046/j.1528-1157.2003.66302.x, 12887430.
24. Schauwecker PE. Seizure-induced neuronal death is associated with induction of c-Jun N-terminal kinase and is dependent on genetic background. Brain Res 2000, 884:116-128. 10.1016/S0006-8993(00)02888-2, 11082493.
25. Schauwecker PE. Complications associated with genetic background effects in models of experimental epilepsy. Prog Brain Res 2002, 135:139-148.
26. Schauwecker PE. Modulation of cell death by mouse genotype: Differential vulnerability to excitatory amino acid-induced lesions. Exp Neurol 2002, 178:219-235. 10.1006/exnr.2002.8038, 12504881.
27. Schauwecker PE, Steward O. Genetic determinants of susceptibility to excitotoxic cell death: implications for gene targeting approaches. Proc Natl Acad Sci USA 1997, 94:4103-4108. 10.1073/pnas.94.8.4103, 20575, 9108112.
28. Schauwecker PE, Ramirez JJ, Steward O. Genetic dissection of the signals that induce synaptic reorganization. Exp Neurol 2000, 161:139-152. 10.1006/exnr.1999.7251, 10683280.
29. Schauwecker PE, Williams RW, Santos JB. Genetic control of sensitivity to hippocampal cell death induced by kainic acid: a quantitative trait loci analysis. J Comp Neurol 2004, 477:96-107. 10.1002/cne.20245, 15281082.
30. Nadler JV, Perry BW, Gentry C, Cotman CW. Degeneration of hippocampal CA3 pyramidal cells induced by intraventricular kainic acid. J Comp Neurol 1980, 192:333-359. 10.1002/cne.901920209, 7400401.
31. Nadler JV, Perry BW, Gentry C, Cotman CW. Loss and reacquisition of hippocampal synapses after selective destruction of CA3-CA4 afferents with kainic acid. Brain Res 1980, 191:387-403. 10.1016/0006-8993(80)91289-5, 7378766.
32. Sperk G, Lassmann H, Baran H, Kish SJ, Seitelberger F, Hornykiewicz O. Kainic acid induced seizures: neurochemical and histopathological changes. Neuroscience 1983, 10:1301-1315. 10.1016/0306-4522(83)90113-6, 6141539.
33. Huang CW, Hsieh YJ, Pai MC, Tsai JJ, Huang CC. Non-ketotic hyperglycemia-related epilepsia partialis continua with ictal unilateral parietal hyperperfusion. Epilepsia 2005, 46:1843-1844. 10.1111/j.1528-1167.2005.00285.x, 16302867.
34. Kaufman FR. Diabetes in children and adolescents. Areas of controversy. Med Clin North Am 1998, 82:721-738. 10.1016/S0025-7125(05)70021-3, 9706118.
35. Singh BM, Strobos RJ. Epilepsia partialis continua associated with nonketotic hyperglycemia: clinical and biochemical profile of 21 patients. Ann Neurol 1989, 8:155-160.
36. Chen JWY, Wasterlain CG. Status epilepticus: pathophysiology and management in adults. Lancet Neurol 2006, 5:246-256. 10.1016/S1474-4422(06)70374-X, 16488380.
37. Lavin PJ. Hyperglycemic hemianopia: a reversible complication of non-ketotic hyperglycemia. Neurology 2005, 65:616-619. 10.1212/01.wnl.0000173064.80826.b8, 16116129.
38. Schwechter EM, Velisková J, Velisek L. Correlation between extracellular glucose and seizure susceptibility in adult rats. Ann Neurol 2003, 53:91-101. 10.1002/ana.10415, 12509852.
39. McCorry D, Nicolson A, Smith D, Marson A, Feltbower RG, Chadwick DW. An association between type 1 diabetes and idiopathic generalized epilepsy. Ann Neurol 2006, 59:204-206. 10.1002/ana.20727, 16374819.
40. Lothman EW, Collins RC. Kainic acid induced limbic seizures: metabolic, behavioral, electroencephalographic and neuropathological correlates. Brain Res 1981, 218:299-318. 10.1016/0006-8993(81)91308-1, 7272738.
41. Ben-Ari Y, Tremblay E, Berger M, Nitecka L. Kainic acid seizure syndrome and binding sites in developing rats. Brain Res 1984, 316:284-288.
42. Nadler JV, Cuthbertson GJ. Kainic acid neurotoxicity toward hippocampal formation: dependence on specific excitatory pathways. Brain Res 1980, 195:47-56. 10.1016/0006-8993(80)90865-3, 6249441.
43. Chapman AG, Engelsen B, Meldrum BS. 2-Amino-7-Phosphonoheptanoic acid inhibits insulin-induced convulsions and striatal aspartate accumulation in rats with frontal cortical ablation. J Neurochem 1987, 49:121-127. 10.1111/j.1471-4159.1987.tb03403.x, 3295120.
44. Kirchner A, Veliskova J, Velisek L. Differential effects of low glucose concentrations on seizures and epileptiform activity in vivo and in vitro. Eur J Neurosci 2006, 223:1512-1522.
45. Ito M, Kondo Y, Nakatani A, Hayashi K, Naruse A. Characterization of low dose streptozotocin-induced progressive diabetes in mice. Environ Toxicol Pharmacol 2001, 9:71-78. 10.1016/S1382-6689(00)00064-8, 11167151.
46. Gastaut H, Lyagoubi S, Mesdjian E, Saier J, Ouahchi S. Generalized epileptic seizures, induced by " non-convulsant" substances. I. Experimental study with special reference to insulin. Epilepsia 1968, 9:311-316. 10.1111/j.1528-1157.1968.tb04964.x, 5255175.
47. Mansford KR, Opie L. Comparison of metabolic abnormalities in diabetes mellitus induced by streptozotocin or by alloxan. Lancet 1968, 1:670-671.
48. Rerup CC. Drugs producing diabetes through damage of the insulin secreting cells. Pharmacol Rev 1970, 22:485-518.
49. Nakamura T, Terajima T, Ogata T, Ueno K, Hashimoto N, Ono K, Yano S. Establishment and pathophysiological characterization of type 2 diabetic mouse model produced by streptozotocin and nicotinamide. Biol Pharm Bull 2006, 29:1167-1174. 10.1248/bpb.29.1167, 16755011.
50. Tesch GH, Allen TJ. Rodent models of sterptozotocin-induced diabetic nephropathy. Nephrology 2007, 12:261-266. 10.1111/j.1440-1797.2007.00796.x, 17498121.
51. Johansen FF, Diemer NH. Influence of the plasma glucose level on brain damage after systemic kainic acid injection in the rat. Acta Neuropathol 1986, 71:46-54. 10.1007/BF00687961, 3776474.
52. Meldrum BS. Metabolic factors during prolonged seizures and their relation to nerve cell death. Adv Neurol 1983, 34:261-275.
53. Sapolsky RM, Stein BA. Status epilepticus-induced hippocampal damage is modulated by glucose availability. Neurosci Lett 1989, 97:157-162. 10.1016/0304-3940(89)90156-0, 2919000.
54. Choi DW. Calcium and excitotoxic neuronal injury. Ann NY Acad Sci 1994, 747:162-171.
55. McBurney RN, Neering IR. The measurements of changes in intracellular free calcium during action potentials in mammalian neurons. J Neurosci Methods 1985, 13:65-76. 10.1016/0165-0270(85)90044-5, 2581101.
56. Wang LY, Dudek EM, Browning MD, MacDonald JF. Modulation of AMPA/kainate receptors in cultured murine hippocampal neurons by protein kinase C. J Physiol 1994, 475:431-437. 1160395, 8006827.
57. Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993, 262:689-695. 10.1126/science.7901908, 7901908.
58. Crompton M, Costi A. Kinetic evidence for a heart mitochondrial pore activated by Ca2+, inorganic phosphate and oxidative stress. A potential mechanism for mitochondrial dysfunction during cellular Ca2+ overload. Eur J Biochem 1988, 178:489-501. 10.1111/j.1432-1033.1988.tb14475.x, 2850179.
59. Duchen MR. Contributions of mitochondria to animal physiology: from homeostatic sensor to calcium signaling and cell death. J Physiol 1999, 516:1-17. 10.1111/j.1469-7793.1999.001aa.x, 2269224, 10066918.
60. Nicholls DG, Budd SL. Mitochondria and neuronal survival. Physiol Rev 2000, 80:315-360.
61. Packer MA, Murphy MP. Peroxynitrite formed by simultaneous nitric oxide and superoxide generation causes cyclosporin-A-sensitive mitochondrial calcium efflux and depolarization. Eur J Biochem 1995, 234:231-239. 10.1111/j.1432-1033.1995.231_c.x, 8529645.
62. Auer RN. Insulin, blood glucose levels, and ischemic brain damage. Neurology 1998, 51S3:S39-S43.
63. Zhu CZ, Auer RN. Optimal blood glucose levels while using insulin to minimize the size of infarction in focal cerebral ischemia. J Neurosurg 2004, 101:664-668. 10.3171/jns.2004.101.4.0664, 15481723.
64. Hamilton MG, Tranmer BI, Auer RN. Insulin reduction of cerebral infarction due to transient focal ischemia. J Neurosurg 1995, 82:262-268. 10.3171/jns.1995.82.2.0262, 7815155.
65. Nagamizo D, Tsuruta S, Matsumoto M, Matayoshi H, Yamashita A, Sakabe T. Tight glycemic control by insulin, started in the preischemic, but not postischemic, period, protects against ischemic spinal cord injury in rabbits. Anesth Analg 2007, 105:1397-1403. 10.1213/01.ane.0000281146.33391.69, 17959972.
66. Huang CW, Cheng JT, Tsai JJ, Wu SN, Huang CC. Diabetes aggravates epileptic seizures and status epilepticus-induced hippocampal damage. Neurotox Res 2009, 15:71-81. 10.1007/s12640-009-9008-2, 19384590.
67. Stafstrom CE. Hyperglycemia lowers seizure threshold. Epilepsy Curr 2003, 3:148-149. 10.1046/j.1535-7597.2003.03415.x, 387262, 15309063.
68. Like AA, Rossini AA. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 1976, 193:415-417. 10.1126/science.180605, 180605.
69. Meldrum B, Garthwaite J. Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol Sci 1990, 11:379-387. 10.1016/0165-6147(90)90184-A, 2238094.
70. Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 1994, 330:613-622. 10.1056/NEJM199403033300907, 7905600.
71. Weiss JH, Sensi SL, Koh JY. Zn(2+): a novel ionic mediator of neural injury in brain disease. Trends Pharmacol Sci 2000, 21:395-401. 10.1016/S0165-6147(00)01541-8, 11050320.
72. Suh SW, Hamby AM, Swanson RA. Hypoglycemia, brain energetic, and hypoglycemic neuronal death. Glia 2007, 55:1280-1286. 10.1002/glia.20440, 17659530.
73. Wieloch T. Hypoglycemia-induced neuronal damage prevented by an N-methyl-D-aspartate antagonist. Science 1985, 230:681-683. 10.1126/science.2996146, 2996146.
74. Friberg H, Ferrand-Drake M, Bengtsson F, Halestrap AP, Wieloch T. Cyclosporin A, but not FK 506, protects mitochondria and neurons against hypoglycemic damage and implicates the mitochondrial permeability transition in cell death. J Neurosci 1998, 18:5151-5159.
75. Blattner RJ. Central nervous system damage and hypoglycemia. J Pediatr 1968, 72:904-906. 10.1016/S0022-3476(68)80447-0, 4870977.
76. Vannucci RC, Vannucci SJ. Hypoglycemic brain injury. Semin Neonatol 2001, 6:147-155. 10.1053/siny.2001.0044, 11483020.
77. Cronberg T, Rytter A, Asztély F, Söder A, Wieloch T. Glucose but not lactate in combination with acidosis aggravates ischemic neuronal death in vitro. Stroke 2004, 35:753-757. 10.1161/01.STR.0000117576.09512.32, 14963271.
78. Faraco G, Fossati S, Bianchi ME, Patrone M, Pedrazzi M, Sparatore B, Moroni F, Chiarugi A. High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivo. J Neurochem 2007, 103:590-603. 10.1111/j.1471-4159.2007.04788.x, 17666052.
79. Racine RJ. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 1972, 32:281-294. 10.1016/0013-4694(72)90177-0, 4110397.
80. Sperk G. Kainic acid seizures in the rat. Prog Neurobiol 1994, 42:1-32. 10.1016/0301-0082(94)90019-1, 7480784.
81. Sidman RL, Angevine JB, Taber Pierce E. Atlas of the Mouse Brain and Spinal Cord 1971, Harvard University Press, Cambridge.
82. Franklin KBJ, Paxinos G. The Mouse Brain in Stereotaxic Coordinates 1997, Academic, New York.
83. Sousa N, Madeira MD, Paula-Barbosa MM. Effects of corticosterone treatment and rehabilitation on the hippocampal formation of neonatal and adult rats. An unbiased stereological study. Brain Res 1998, 794:199-210.
84. West MJ, Slomianka L, Gundersen HJ. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionators. Anat Rec 1991, 231:482-497. 10.1002/ar.1092310411, 1793176.